↓ Skip to main content

Dove Medical Press

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, January 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
Title
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland
Published in
ClinicoEconomics and Outcomes Research: CEOR, January 2023
DOI 10.2147/ceor.s391455
Pubmed ID
Authors

Taru Hallinen, Santtu Kivelä, Erkki Soini, Veli-Pekka Harjola, Mari Pesonen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 26%
Student > Bachelor 2 11%
Researcher 1 5%
Student > Postgraduate 1 5%
Student > Master 1 5%
Other 0 0%
Unknown 9 47%
Readers by discipline Count As %
Unspecified 5 26%
Nursing and Health Professions 2 11%
Mathematics 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Business, Management and Accounting 1 5%
Other 1 5%
Unknown 8 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2023.
All research outputs
#20,727,202
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#445
of 525 outputs
Outputs of similar age
#352,274
of 476,345 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#5
of 6 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 476,345 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.